Press Releases
US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors
Hover to Know More
'Game Changer' Blood Test Detects Breast Cancer
‘Game-changer’ blood test
detects breast cancer earlier
than X-rays, study shows
Hover to Know More
Landmark Liquid Biopsy Study
Landmark Liquid Biopsy Study Shows Accurate Detection of Early-Stage Breast Cancer
Study establishes the high clinical performance of ‘Trucheck™ - Breast’ blood test.
Hover to Know More
The London Clinic News
Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services
Hover to Know More
FDA News - Prostate Cancer
Datar’s TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation.
Hover to Know More
South Africa - News
Groundbreaking’ high-sensitivity cancer-screening test arriving in SA ahead of World Cancer Day.
Hover to Know More
Kuwait - News
Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait.
Hover to Know More
FDA News - Breast Cancer
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics.
Hover to Know More
The Healthcare Technology Report
The Top 25 Women Leaders in Biotechnology of 2021
(Swati Deshpande - Datar Cancer Genetics).
Hover to Know More
NICE - UK
UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer'.
Hover to Know More